相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome
Heleen D. de Koning et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype
L. van Bon et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions
Maria Stella Graziani et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Schnitzler's syndrome: lessons from 281 cases
Heleen D. de Koning
CLINICAL AND TRANSLATIONAL ALLERGY (2014)
Schnitzler's syndrome: diagnosis, treatment, and follow-up
A. Simon et al.
ALLERGY (2013)
Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4
Dirk Foell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
Heleen D. de Koning et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers
Christoph Kessel et al.
CLINICAL IMMUNOLOGY (2013)
Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma
Kan-ichi Iwama et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
David Launay et al.
PLOS ONE (2013)
Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
Jasmin B. Kuemmerle-Deschner et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
K. Krause et al.
ALLERGY (2012)
The NLRP3/ASC/Caspase-1 axis regulates IL-1ß processing in neutrophils
Arun K. Mankan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Strong induction of AIM2 expression in human epidermis in acute and chronic inflammatory skin conditions
Heleen D. de Koning et al.
EXPERIMENTAL DERMATOLOGY (2012)
Pattern Recognition Receptors in Immune Disorders Affecting the Skin
Heleen D. de Koning et al.
JOURNAL OF INNATE IMMUNITY (2012)
MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes
Helmut Wittkowski et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
Heleen D. de Koning et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Characterization of the B-cell compartment in a patient with Schnitzler syndrome
A. Sediva et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)
Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review
Emilio Besada et al.
CLINICAL RHEUMATOLOGY (2010)
A Comprehensive Analysis of Pattern Recognition Receptors in Normal and Inflamed Human Epidermis: Upregulation of Dectin-1 in Psoriasis
Heleen D. de Koning et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
The Schnitzler syndrome
Dan Lipsker
ORPHANET JOURNAL OF RARE DISEASES (2010)
Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome
Anna Simon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Schnitzler syndrome: response to anakinra in two cases and a review of the literature
Christian Schuster et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
John A. Lust et al.
MAYO CLINIC PROCEEDINGS (2009)
Dysfunctional inflammasome in Schnitzler's syndrome
Cinzia Pizzirani et al.
RHEUMATOLOGY (2009)
IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
John G. Ryan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Acute Kawasaki disease is associated with reverse regulation of with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12
Helmut Wittkowski et al.
ARTHRITIS AND RHEUMATISM (2007)
Schnitzler syndrome: Beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment
Heleen D. de Koning et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2007)
Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl et al.
NATURE MEDICINE (2007)
Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2007)
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
HD de Koning et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis
GJ de Jongh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Successful treatment of refractory Schnitzler syndrome with anakinra:: comment on the article by Hawkins et
VM Martinez-Taboada et al.
ARTHRITIS AND RHEUMATISM (2005)
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
D Foell et al.
GUT (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The Schnitzler syndrome - Four new cases and review of the literature
D Lipsker et al.
MEDICINE (2001)
分享论文
